It is well recognized that obesity is a widespread and growing problem, not only for the developed world but also for developing countries. The prevalence data for the UK show that 50% of the adult population is overweight and 20% is obese. The disease is clearly beginning in childhood and there are now well documented increases in childhood obesity in most societies around the globe. This rising prevalence in obesity (de¢ned by the WHO as an epidemic) will predate an explosion in the demand for health care resources as the problems of obesity-related co-morbidities become clinically evident. These three papers establish the evidence for the metabolic e¡ects of obesity in children.
It is well recognized that obesity is a widespread and growing problem, not only for the developed world but also for developing countries. The prevalence data for the UK show that 50% of the adult population is overweight and 20% is obese. The disease is clearly beginning in childhood and there are now well documented increases in childhood obesity in most societies around the globe. This rising prevalence in obesity (de¢ned by the WHO as an epidemic) will predate an explosion in the demand for health care resources as the problems of obesity-related co-morbidities become clinically evident. These three papers establish the evidence for the metabolic e¡ects of obesity in children.
Sinha et al. studied the prevalence of diabetes and impaired glucose tolerance in obese Hispanic and black children and adolescents attending a paediatric obesity clinic. There is currently a debate about the de¢nition of obesity in children, and these authors used age-and sex-related 95th centiles. Formal oral GTTs were performed and impaired glucose tolerance was found in 25% of the children and 21% of the adolescents. Moreover, 4% of the adolescents had frank diabetes. In this cross-sectional study, the most important risk markers for impaired glucose tolerance were fasting hyperinsulinaemia and hyperproinsulinaemia. All the children were from ethnic groups and no comment was made about the lack of white children in the series.
Whincup et al. took a di¡erent approach by looking for glucose intolerance in randomly selected children from 10 towns across the UK. Children aged 8^11 years were examined and blood taken either in the fasting state or 2 h after a glucose load. They found that plasma insulin in both the fasting and post-glucose states increased proportionally with the traditional risk markers for insulin resistance, i.e. weight and waist circumference, but that the degree of hyperinsulinaemia was ampli¢ed in children of South Asian origin. The insulin concentrations were increased across the weight and waist circumference range and, after adjustment for age and sex, were 450% greater in the Asian children.
The inevitable outcome has been reported by Drake et al., who describe four white adolescents in England with type 2 diabetes with underlying insulin resistance. They describe this development as a direct consequence of obesity. Although a few cases have been published previously, these have all been in ethnic groups with a predisposition to diabetes.
These reports con¢rm that the relationship between obesity and diabetes is present in children and also highlight the increased risk in some ethnic groups.
Screening Direct-to-consumer marketing of high-technology screening tests
Lee TH, Brennan TA New Engl J Med 2002; 346: 529-31
Lee and Brennan have written a thought-provoking article about the advertising of expensive screening tests directly to the consumer, using the examples of computerized tomography for the diagnosis of coronary artery disease and lung cancers^tests which cost US$300 -1000. Proponents argue that individuals should not have to wait until de¢nitive evidence becomes available before they can bene¢t from these tests, and that consumers should have the right to spend their funds as they will. However, the authors disagree and argue cogently against this approach to the use of diagnostic tests, on the basis of available clinical evidence, the ¢nancial costs to the health care system, and the ethics and responsibilities of physicians. This will strike a chord with most clinical biochemists who have for many years seen the introduction of screening tests, despite a lack of speci¢city, by stealth, albeit in a rather random way.
